What is psoriasis?
Psoriasis is a chronic, immune-mediated inflammatory skin disease that causes skin cells to grow much faster than normal, leading to thick, scaly plaques on the skin. It is not contagious and typically follows a relapsing-remitting course, with periods of flares and improvement.
What are the causes?
The exact cause of psoriasis is not fully understood, but it is considered to be a multifactorial disease with immune-mediated and genetic factors playing a role.
What are the triggering factors?
● Infections (e.g., Streptococcus throat infection)
● Certain drugs (e.g., β-blockers, lithium)
● Physical trauma to the skin (Koebner phenomenon)
● High stress levels
● Cold and dry weather
● Smoking or alcohol use
● Obesity
What are the common types of psoriasis?
The main types of psoriasis include:
● Plaque psoriasis (the most common type, accounting for about 80–90% of cases)
● Guttate psoriasis
● Inverse (flexural) psoriasis
● Pustular psoriasis
● Erythrodermic psoriasis
What is plaque psoriasis?
Plaque psoriasis is the most common form of psoriasis, characterized by sharply defined, erythematous plaques covered with silvery-white scales.
What are the clinical features of plaque psoriasis?
● Symmetrically distributed, well demarcated erythematous plaques covered with silvery-white scales
● The most common sites are the extensor surfaces (elbows, knees), scalp, and lower back
● Auspitz sign which is a pinpoint bleeding after removal of scales
● May be associated with psoriatic arthritis (joint pain and stiffness)
● Nail involvement may occur
What are the treatment options?
General measures
- Emollient
- Avoid triggers such as stop smoking
Mild disease
- Topical corticosteroids
- Topical vitamin D analogs (calcipotriol)
- Topical calcineurin inhibitors
Moderate to severe disease
- Phototherapy: narrowband UVB, PUVA, or excimer laser
- Systemic agents: methotrexate, cyclosporine, or acitretin
- Biologic therapy: TNF-α inhibitors, IL-17 inhibitors, IL-23 inhibitors, or IL-12/23 inhibitors
Scientific Content: Dr. Omniyyah Hawsawi
Reference: DermNet